RESUMEN
Acute myocardial infarction is a rare form of presentation in patients with left atrial myxoma. With wider availability of echocardiography, more and more patients with atrial myxomas will be diagnosed. This report describes a patient with left atrial myxoma who presented features of acute myocardial infarction and had surgical removal of LA myxoma.
Asunto(s)
Neoplasias Cardíacas/diagnóstico , Infarto del Miocardio/diagnóstico , Mixoma/diagnóstico , Adulto , Procedimientos Quirúrgicos Cardíacos , Puente Cardiopulmonar , Angiografía Coronaria , Diagnóstico Diferencial , Ecocardiografía , Electrocardiografía , Femenino , Atrios Cardíacos/patología , Atrios Cardíacos/cirugía , Neoplasias Cardíacas/cirugía , Humanos , Mixoma/cirugía , Disfunción Ventricular Izquierda/diagnóstico , Disfunción Ventricular Izquierda/cirugíaAsunto(s)
Inteligencia Artificial , Astrocitoma/diagnóstico , Neoplasias Encefálicas/diagnóstico , Imagen por Resonancia Magnética/estadística & datos numéricos , Meningioma/diagnóstico , Ingeniería Biomédica , Bases de Datos Factuales , Diagnóstico por Computador , Diagnóstico Diferencial , Humanos , LógicaRESUMEN
The effectiveness of radiotherapy in the treatment of malignant tumors in the head and neck, thorasic and upper abdominal regions is frequently limited by the tolerance of the spinal cord. Therefore knowledge of the factors that influence the tolerance of the spinal cord to radiation is of the upmost important. Safe limits for irradiation of the spinal cord determined in a number of clinical studies is on the conservative side from the point of view of tumor control probability. The bioeffect of a physical dose takes into account the treatment variables and the radiobiological characteristics of the relevant tissue; hence deciding spinal cord tolerance on the basis of bioeffect models would be better approach. The aim of the present study was to analyze the relationship of the prognostic factors with percentage incidence of spinal cord myelitis and to arrive at a spinal cord tolerance bioeffect dose TDF and ERD for optimum incidence of radiation myelitis.